Access cutting-edge hiv prevention treatment through this clinical trial at a research site in Palm Springs. Study-provided care at no cost to qualified participants.
Access hiv prevention specialists in Palm Springs at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv prevention treatment provided free
The goal of this clinical study is to learn more about the study drug lenacapavir (LEN), safety, tolerability, and pharmacokinetics (how LEN is absorbed, modified, distributed, and removed from the body of the participants) of once-yearly intramuscular for HIV pre-exposure prophylaxis (PrEP) in people with an indication for PrEP. The primary objective of this study is to evaluate the pharmacokinetics (PK) and the safety and tolerability of intramuscular (IM) every 12 months (Q12M) LEN for PrEP
Sponsor: Gilead Sciences
Check if you qualify for this hiv prevention clinical trial in Palm Springs, CA
If you're searching for hiv prevention treatment options in Palm Springs, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palm Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv prevention specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.